Literature DB >> 2370299

A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils.

G L Hammond1, C L Smith, N A Paterson, W J Sibbald.   

Abstract

In human blood, cortisol is transported by a plasma protein known as corticosteroid-binding globulin (CBG). As anticipated from primary structure comparisons of CBG and alpha 1-proteinase inhibitor (A1-PI), CBG acts as a substrate for neutrophil elastase. However, unlike A1-PI, CBG does not alter the activity of this enzyme, but is cleaved by it at a single location close to its carboxy-terminus, and this reduces its molecular size by 5 kDa with the concomitant release of more than 80% of CBG-bound cortisol. Three small molecular size fragments are detected after elastase cleavage, and carbohydrate analysis of these fragments suggests that they represent the same polypeptide fragment which has been differentially glycosylated. To assess the biological significance of these observations, CBG was incubated with either mononuclear cells or granulocytes obtained from patients with acute inflammation (sepsis) and from a normal volunteer. Only granulocytes from septic patients reduced the mol wt of CBG by about 5 kDa and destroyed its steroid-binding activity. Preincubation with A1-PI prevented this, which demonstrates that neutrophil elastase plays a key role in this event. These results suggest a physiological role for CBG in the delivery of cortisol to sites of inflammation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370299     DOI: 10.1210/jcem-71-1-34

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  45 in total

1.  Modeling of human corticosteroid binding globulin. Use of structure-activity relations in soft steroid binding to refine the structure.

Authors:  Roy J Little; C G Rodríguez
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

2.  Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man.

Authors:  J A Wald; R M Law; E A Ludwig; R R Sloan; E Middleton; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1992-12

3.  Pseudomonas aeruginosa elastase disrupts the cortisol-binding activity of corticosteroid-binding globulin.

Authors:  Marc Simard; Lesley A Hill; Caroline M Underhill; Bernd O Keller; Ivan Villanueva; Robert E W Hancock; Geoffrey L Hammond
Journal:  Endocrinology       Date:  2014-05-21       Impact factor: 4.736

4.  Corticosteroid-binding globulin is a biomarker of inflammation onset and severity in female rats.

Authors:  Lesley A Hill; Tamara S Bodnar; Joanne Weinberg; Geoffrey L Hammond
Journal:  J Endocrinol       Date:  2016-08       Impact factor: 4.286

Review 5.  Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?

Authors:  Elise P Gomez-Sanchez
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 6.  Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.

Authors:  F Hervé; S Urien; E Albengres; J C Duché; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

Review 7.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

8.  Homology model of human corticosteroid binding globulin: a study of its steroid binding ability and a plausible mechanism of steroid hormone release at the site of inflammation.

Authors:  Raja Dey; Priyobroto Roychowdhury
Journal:  J Mol Model       Date:  2003-05-06       Impact factor: 1.810

9.  Modulation of testosterone-dependent male sexual behavior and the associated neuroplasticity.

Authors:  Thierry D Charlier; Aurore L Seredynski; Neville-Andrew Niessen; Jacques Balthazart
Journal:  Gen Comp Endocrinol       Date:  2013-03-20       Impact factor: 2.822

10.  Free and bound cortisol in plasma and saliva during ACTH challenge in dairy cows and horses.

Authors:  Ann-Catherine Schwinn; Fay J Sauer; Vincenz Gerber; Rupert M Bruckmaier; Josef J Gross
Journal:  J Anim Sci       Date:  2018-02-15       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.